Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.
Humanlinker is an innovative company that specializes in artificial intelligence-guided technology aimed at enhancing the effectiveness of revenue generation teams. Its platform facilitates the development of account-based selling strategies by providing users with AI-driven account recommendations and identifying strategic accounts that are primed for sales engagement. The technology enables sales teams to track relevant data, allowing for a comprehensive understanding of accounts and improving sales interactions. By leveraging advanced algorithms, Humanlinker's solutions support companies in optimizing their sales processes and achieving better outcomes in revenue generation.
Sitowie is a company that specializes in developing software as a service (SaaS) technology aimed at understanding and managing the degradation of buildings. Utilizing artificial intelligence and machine learning, Sitowie's platform assists clients in anticipating risks associated with the aging of structures. The tools provided by the company not only enhance the sustainability of buildings but also contribute to cost reduction and facilitate effective arbitration processes. By focusing on the preservation and sustainability of heritage properties, Sitowie aims to support clients in making informed decisions regarding building maintenance and management.
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
Tallano Technologie is a French company founded in 2012, based in Boulogne-Billancourt, that specializes in reducing particle emissions from vehicle braking systems. The company has developed a proprietary technology known as tamic, which effectively captures particles at the source through suction. This innovative particle collector is designed to be installed between the brake disc and pad in both private cars and public transport vehicles. Tallano Technologie positions itself as a leader in the field of particle emission reduction, addressing environmental concerns associated with vehicular braking systems.
UpFactor is an independent advisory firm based in Paris, France, specializing in the large-scale analysis of aerial land potential. Founded in 2017, the company utilizes a geographic information system that aggregates essential data for site analysis, including addresses, street widths, building heights, land use regulations, solar land registers, and protected areas. With a focus on providing comprehensive insights, UpFactor combines expertise in architecture, engineering, and law to assist clients in understanding the development potential of various sites.
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.
Developer of a search engine platform intended to help users find and compare all accommodation places. The company's platform offers customizable search options, multiple filters, results displayed on a map, and tools to help find accommodation for hotels, apartments, houses, youth hostels, lodges, boats, treehouses, and more, enabling users to find satisfactory and comparable deals at a reasonable price.
Developer of a search engine platform intended to help users find and compare all accommodation places. The company's platform offers customizable search options, multiple filters, results displayed on a map, and tools to help find accommodation for hotels, apartments, houses, youth hostels, lodges, boats, treehouses, and more, enabling users to find satisfactory and comparable deals at a reasonable price.
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.
Misakey SAS is a company based in Paris, France, that specializes in developing a personal data protection platform aimed at managing digital identities. Founded in 2018, Misakey's platform enables users to access and control their personal data across various social media and online platforms. It allows individuals to recover their data, request updates, and initiate deletions or restrictions, thereby empowering them to reclaim control over their personal information. Additionally, the platform facilitates collaboration for webmasters to integrate applications and create compliant websites, enhancing overall data security and management.
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
AppScho, SAS is a Paris-based company founded in 2014 that specializes in developing mobile application software for the higher education sector. The application centralizes various intranet information, enabling students to easily access their schedules, grades, school events, and internship opportunities. It provides functionalities for students to preview upcoming courses, including classroom details and instructor information, while also sending notifications for any class changes. Additionally, the platform allows educational institutions and teachers to communicate with students, monitor engagement levels, and analyze academic performance. By streamlining access to essential information, AppScho aims to enhance student engagement and simplify communication within educational environments.
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.
Precogs is a company specializing in business analytics solutions, focusing on the electronic components sector. Founded in 2011 and based in Paris, France, Precogs provides tools for supply risk management, enterprise resource planning (ERP), and procurement monitoring. Their key products include CogWatch, a big data predictive tool designed to enhance decision-making, and Cog Margin, a platform that aids in component pricing. The company primarily assists EMS, OEM, and ODM businesses in sourcing competitive prices for electronic components in real-time, thereby streamlining procurement processes and optimizing cost-efficiency.
PayinTech SAS, founded in 2010 and based in Paris, France, specializes in cashless payment solutions utilizing NFC technology. The company initially developed a payment system using wristbands and terminals for a student bar, which later evolved into a scalable solution for large events. PayinTech gained recognition as the provider of the first fully cashless festival in Europe in 2012, managing payments for 14,000 attendees. The company has since grown into a leading player in the fintech sector, securing significant funding to enhance research and development. Its software integrates monetary transactions with management, inventory, and customer relationship tools, primarily serving the entertainment and tourism industries. PayinTech's solutions are implemented in various venues, including resorts, amusement parks, and events across 16 countries, enabling clients to streamline financial operations, boost on-site revenues, and enhance user experiences.
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.
AppScho, SAS is a Paris-based company founded in 2014 that specializes in developing mobile application software for the higher education sector. The application centralizes various intranet information, enabling students to easily access their schedules, grades, school events, and internship opportunities. It provides functionalities for students to preview upcoming courses, including classroom details and instructor information, while also sending notifications for any class changes. Additionally, the platform allows educational institutions and teachers to communicate with students, monitor engagement levels, and analyze academic performance. By streamlining access to essential information, AppScho aims to enhance student engagement and simplify communication within educational environments.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
Linkfluence is a social media intelligence company that focuses on analyzing online conversations across various platforms, including social networks, blogs, and forums, to create business opportunities for brands. Its flagship product, the Radarly Product Suite, is a user-friendly, multilingual software-as-a-service solution designed to monitor, measure, and engage with social media content effectively. Radarly aids in reputation management, influencer engagement, community management evaluation, crisis detection, and best practice identification. Linkfluence also supports companies in customizing the tool to meet specific needs such as performance analysis, brand perception audits, and trend research. With over 200 prominent clients in Europe, Linkfluence empowers organizations to enhance their social strategies by leveraging social data intelligence. The company is backed by several venture capital firms, indicating strong investor confidence in its innovative approach to social media analysis.
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.
Bnbsitter is a Paris-based company that provides concierge rental services for vacation hosts. Established in 2013, the company facilitates the booking of essential welcome services, allowing hosts to efficiently manage guest check-ins and check-outs, as well as rental cleaning, all within a two-minute timeframe. Bnbsitter aims to assist hosts who may be busy, traveling, or otherwise unable to personally greet their guests, ensuring that visitors receive a warm welcome. In addition to these services, the company offers a comprehensive online platform that includes features such as tenant search, lease signing, and maintenance management, catering to the needs of both hosts and guests in the temporary rental market.
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.
Aterovax is an in vitro diagnostic company focused on developing innovative solutions for the prediction, diagnosis, and prevention of cardiovascular disease. With a unique understanding of atherosclerosis, Aterovax creates diagnostic tests that assess the level of atherosclerotic plaque development in patients. These tests aim to provide insights into cardiovascular risk, enabling more effective management and intervention strategies for individuals at risk of cardiovascular conditions.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.
RED Technologies specializes in developing innovative spectrum-sharing solutions aimed at addressing the growing demand for accessible and affordable wireless services. Their cloud-based spectrum access system operates within a three-tier hierarchy, facilitating effective spectrum sharing while ensuring the protection of users across different tiers. By offering end-to-end dynamic spectrum sharing solutions, RED Technologies contributes to addressing spectrum shortages, thereby supporting broader wireless market growth and fostering positive changes in both the economy and society.
English Attack is an online platform dedicated to English language learning, targeting independent teachers, schools, universities, language institutes, and companies in Greece and Cyprus. Founded in 2009 and based in Paris, the platform offers a unique approach by using digital entertainment to enhance language acquisition. Its offerings include interactive video exercises based on popular movies, TV series, music, and current events, along with visual dictionaries and engaging language games that help users practice vocabulary and comprehension skills. The service is available through subscription models for individual learners, multi-user licenses for educational institutions, and language training programs for companies. English Attack emphasizes a fun and engaging learning experience, positioning itself within the growing $35 billion English language learning market.
PayinTech SAS, founded in 2010 and based in Paris, France, specializes in cashless payment solutions utilizing NFC technology. The company initially developed a payment system using wristbands and terminals for a student bar, which later evolved into a scalable solution for large events. PayinTech gained recognition as the provider of the first fully cashless festival in Europe in 2012, managing payments for 14,000 attendees. The company has since grown into a leading player in the fintech sector, securing significant funding to enhance research and development. Its software integrates monetary transactions with management, inventory, and customer relationship tools, primarily serving the entertainment and tourism industries. PayinTech's solutions are implemented in various venues, including resorts, amusement parks, and events across 16 countries, enabling clients to streamline financial operations, boost on-site revenues, and enhance user experiences.
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.
Open Ocean is an innovative company based in Brest and Paris, which conceives since 2011 online decision-making solutions for industrial marine activities.
Their highly qualified team of oceanographers, trained in the best research oceanographic institutes of the world (UPMC, IFREMER, University of Washington) is specialized in high resolution modelling, statistical analysis and data mining.
Web Geo Services SAS, founded in 2009 and headquartered in Montpellier, France, specializes in online mapping and geolocation applications. The company provides location-based software as a service (SaaS) technology tailored for various industries, including retail, e-commerce, travel, hospitality, banking, and automotive. By leveraging Google Maps, Web Geo Services assists businesses in enhancing customer engagement and driving conversions through effective digital systems. The company has established itself as a leading partner of Google Cloud in Europe and has successfully collaborated with more than 400 large companies. Its flagship product, Woosmap, is recognized for enabling developers to integrate advanced location intelligence features into mobile applications and websites. Web Geo Services focuses on delivering innovative solutions that empower clients to optimize online customer journeys and boost revenue.
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.
Precogs is a company specializing in business analytics solutions, focusing on the electronic components sector. Founded in 2011 and based in Paris, France, Precogs provides tools for supply risk management, enterprise resource planning (ERP), and procurement monitoring. Their key products include CogWatch, a big data predictive tool designed to enhance decision-making, and Cog Margin, a platform that aids in component pricing. The company primarily assists EMS, OEM, and ODM businesses in sourcing competitive prices for electronic components in real-time, thereby streamlining procurement processes and optimizing cost-efficiency.
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.
Aterovax is an in vitro diagnostic company focused on developing innovative solutions for the prediction, diagnosis, and prevention of cardiovascular disease. With a unique understanding of atherosclerosis, Aterovax creates diagnostic tests that assess the level of atherosclerotic plaque development in patients. These tests aim to provide insights into cardiovascular risk, enabling more effective management and intervention strategies for individuals at risk of cardiovascular conditions.
AlephD SAS provides publishers with real-time optimization strategies together with business intelligence solutions. It offers YieldEngine, a real-time yield management solution for AppNexus; InstantPredict, which addresses publishers’ constant need to decide what source of revenue to prioritize; and InventoryLab, an integrated software suite to help publishers to make decisions based on data analysis and business intelligence tools. The company was incorporated in 2012 and is based in Paris, France. As of January 25, 2016, AlephD SAS operates as a subsidiary of AOL Inc.
Fidzup is a Paris-based company that specializes in indoor localization and local marketing solutions for brick-and-mortar businesses. Established in 2011, Fidzup has developed an innovative platform that integrates Wi-Fi and GPS technology to track mobile user behavior within retail spaces. This technology allows retailers to analyze consumer movements and interactions, enabling them to send personalized advertisements directly to customers' mobile devices when they enter a store. By leveraging real-time data and analytics, Fidzup aims to enhance customer engagement and optimize marketing strategies for physical retail environments.
Fidzup is a Paris-based company that specializes in indoor localization and local marketing solutions for brick-and-mortar businesses. Established in 2011, Fidzup has developed an innovative platform that integrates Wi-Fi and GPS technology to track mobile user behavior within retail spaces. This technology allows retailers to analyze consumer movements and interactions, enabling them to send personalized advertisements directly to customers' mobile devices when they enter a store. By leveraging real-time data and analytics, Fidzup aims to enhance customer engagement and optimize marketing strategies for physical retail environments.
WeCook is the new companion for a better nutrition and a better health. It uses his meal planner and the Alantaya's technology in order to offer the best high personnalized nutritionnal recommandation and the best coaching with dieteticians. High personnalized nutritionnal recommandation goes from Cancer to pregnancy.
GreenPoint specialises in regtech, namely in digital and mobile management of know your customer (KYC), digital processing of customers’ records and customer on-boarding.
EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.
Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.
Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.
Up & Net SAS, established in 2005 and headquartered in Paris, France, specializes in e-payment services tailored for e-commerce. The company focuses on developing innovative gift card solutions that are utilized by online merchants. In addition to its core offerings, Up & Net publishes Cadeaux-avenue.com, a gift-giving platform, and Monblogshopping.com, a collection of blogs centered around shopping. The company also creates private e-payment programs and distributes e-gift cards, which can be re-materialized for use in convenience stores. Through these services, Up & Net aims to enhance the shopping experience for consumers and provide valuable tools for online retailers.
Sesamea is a French company that specializes in electronic gift and cash cards, which can be redeemed at various retailers and stores across the country. The company offers an e-commerce platform that allows users to purchase tailor-made gift cards online, facilitating a seamless shopping experience. Customers can use these cards to buy a wide range of products, either in physical stores or through online shopping sites. By partnering with numerous retailers, Sesamea provides a versatile and convenient payment solution for consumers looking to give or receive gifts.
Maeglin Software specializes in developing innovative mobile Value Added Services for the telecommunications industry. The company focuses on creating peer-to-peer software solutions that facilitate the sharing of online mobile content. Its services enable users to access and share backed-up contacts, pictures, videos, and documents through both web and mobile platforms. By prioritizing mobile data protection and cost control, Maeglin Software aims to enhance the overall mobile experience for users.
Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, focusing on 5G and 4G technologies for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company has developed a comprehensive product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, which cater to massive IoT applications with low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans offers the Cassiopeia Cat 4/Cat 6 4G and Taurus 5G chip platforms, optimized for residential, enterprise, and industrial use. The company's solutions are integral to various devices, such as smartphones, portable routers, and other connected technologies, and are certified for deployment in global 4G networks. Sequans maintains additional offices in several countries, including the United States, the United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.
Nanobiotix SA is a clinical-stage nanomedicine company based in Paris, France, focused on innovative cancer treatments. Founded in 2003, the company develops NanoXray products designed to enhance the effectiveness of radiotherapy by increasing the impact on tumor cells while minimizing exposure to surrounding healthy tissues. One of its primary offerings is NBTXR3, a radio-enhancer composed of hafnium oxide, which targets various solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, and glioblastoma. In addition to NBTXR3, Nanobiotix is also involved in research programs exploring the use of magnetic particles and laser-activated nanoparticles for cancer treatment and diagnostics.
Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, focusing on 5G and 4G technologies for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company has developed a comprehensive product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, which cater to massive IoT applications with low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans offers the Cassiopeia Cat 4/Cat 6 4G and Taurus 5G chip platforms, optimized for residential, enterprise, and industrial use. The company's solutions are integral to various devices, such as smartphones, portable routers, and other connected technologies, and are certified for deployment in global 4G networks. Sequans maintains additional offices in several countries, including the United States, the United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.
Echosens SAS, established in 2001 and based in Paris, France, specializes in developing, manufacturing, and marketing non-invasive diagnostic products and services for hepatology. The company offers several key technologies, including FibroScan, which utilizes vibration-controlled transient elastography for liver assessment in both clinical practice and research settings. Additionally, Echosens provides FibroMeter, a blood test that quantifies liver fibrosis, and FibroView, a smart connectivity software that integrates FibroScan with hospital information systems. Echosens aims to become a global leader in non-invasive hepatology diagnostics while focusing on improving patient quality of life.
Xcalia specializes in intermediation software that enables the creation of dynamic transactional composite applications. Its flagship Xcalia Intermediation Platform integrates legacy systems, mainframe resources, and databases with web services, facilitating the dynamic orchestration of business processes. By utilizing metadata to describe services, the platform automates transaction execution at runtime, allowing enterprises to swiftly adapt to evolving business needs without the expensive overhead of manual integration. Founded in 2000 and headquartered in Paris, France, Xcalia serves over 50 companies, effectively powering high-volume transactional environments. The company also maintains offices in the United States, the United Kingdom, and Germany.
Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, focusing on 5G and 4G technologies for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company has developed a comprehensive product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, which cater to massive IoT applications with low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans offers the Cassiopeia Cat 4/Cat 6 4G and Taurus 5G chip platforms, optimized for residential, enterprise, and industrial use. The company's solutions are integral to various devices, such as smartphones, portable routers, and other connected technologies, and are certified for deployment in global 4G networks. Sequans maintains additional offices in several countries, including the United States, the United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.
Oralance is a developer of a new oral drug delivery system. Its technology is applied to a wide range of pharmaceuticals in the form of syrups, tablets, powder to dilute, lyophilic, gel, paste forms, and aqueous suspensions and is based on an original galenic micro-encapsulation process.
Xcalia specializes in intermediation software that enables the creation of dynamic transactional composite applications. Its flagship Xcalia Intermediation Platform integrates legacy systems, mainframe resources, and databases with web services, facilitating the dynamic orchestration of business processes. By utilizing metadata to describe services, the platform automates transaction execution at runtime, allowing enterprises to swiftly adapt to evolving business needs without the expensive overhead of manual integration. Founded in 2000 and headquartered in Paris, France, Xcalia serves over 50 companies, effectively powering high-volume transactional environments. The company also maintains offices in the United States, the United Kingdom, and Germany.